| Rosemary Ongaki, NP-C | |
|
640 S Queen St, Dover, DE 19904-3565 | |
| (302) 734-2444 | |
| Not Available |
| Full Name | Rosemary Ongaki |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 640 S Queen St, Dover, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487085361 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | LG-0000695 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geriatric Medicine Consultants Pa | 0244492072 | 21 |
News Archive
Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
New research from ASPIRE2025, a University of Otago research theme, challenges tobacco companies' claims they are working towards a smoke-free world and suggests young people are vulnerable to tobacco companies' product innovations.
A world-leading taskforce led by The University of Manchester has begun work to create a new test to help medics work out which treatment plan is most likely to improve the disabling skin condition psoriasis, based on a patient's individual biological make-up.
› Verified 3 days ago
| Entity Name | Family Health Of Delaware |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952332314 PECOS PAC ID: 4789631268 Enrollment ID: O20050406000947 |
News Archive
Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
New research from ASPIRE2025, a University of Otago research theme, challenges tobacco companies' claims they are working towards a smoke-free world and suggests young people are vulnerable to tobacco companies' product innovations.
A world-leading taskforce led by The University of Manchester has begun work to create a new test to help medics work out which treatment plan is most likely to improve the disabling skin condition psoriasis, based on a patient's individual biological make-up.
› Verified 3 days ago
| Entity Name | Geriatric Medicine Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598031643 PECOS PAC ID: 0244492072 Enrollment ID: O20120424000410 |
News Archive
Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
New research from ASPIRE2025, a University of Otago research theme, challenges tobacco companies' claims they are working towards a smoke-free world and suggests young people are vulnerable to tobacco companies' product innovations.
A world-leading taskforce led by The University of Manchester has begun work to create a new test to help medics work out which treatment plan is most likely to improve the disabling skin condition psoriasis, based on a patient's individual biological make-up.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosemary Ongaki, NP-C 640 South Queen St, Dover, DE 19904-3565 Ph: (302) 734-2444 | Rosemary Ongaki, NP-C 640 S Queen St, Dover, DE 19904-3565 Ph: (302) 734-2444 |
News Archive
Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center.
PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
New research from ASPIRE2025, a University of Otago research theme, challenges tobacco companies' claims they are working towards a smoke-free world and suggests young people are vulnerable to tobacco companies' product innovations.
A world-leading taskforce led by The University of Manchester has begun work to create a new test to help medics work out which treatment plan is most likely to improve the disabling skin condition psoriasis, based on a patient's individual biological make-up.
› Verified 3 days ago
Kamishia Latasha Thomas, ANP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St Ste 340, Dover, DE 19904 Phone: 302-734-1414 Fax: 302-734-2121 | |
Jonelle Murph, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 642 South Queen Street, Ste 102, Dover, DE 19904 Phone: 800-818-8680 Fax: 866-229-0237 | |
Mrs. Angela Erin Knotts, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1673 S State St Ste B, Dover, DE 19901 Phone: 855-527-7246 Fax: 866-229-5063 | |
Reny Varghese, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1225 Walker Rd # 6541, Dover, DE 19904 Phone: 302-734-1199 | |
Michelle L Leite, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St, Suite 170, Dover, DE 19904 Phone: 302-674-1999 | |
Lisa Anne Wullschleger, WHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 805 River Rd, Kent County Public Health Family Planning, Dover, DE 19901 Phone: 302-739-4728 Fax: 302-739-7735 | |
Linda Ann Ashley, CFNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 260 Beiser Blvd Ste 201, Dover, DE 19904 Phone: 302-678-7438 Fax: 302-678-7434 |